How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | CBRSCerebras Systems Inc. | ALABAstera Labs, Inc. | MRVLMarvell Technology, Inc. | MCHPMICROCHIP TECHNOLOGY INC | Median of the restexcluding CBRS |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $117.98▼ 0.26 (0.22%) | $257.82▼ 32.24 (11.11%) | $223.47▼ 21.29 (8.70%) | $74.52▼ 2.63 (3.41%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 6.0/10 | 10.0/10 | 8.0/10 | 7.0/10 | 8.0/10 |
| Market value | $25.38B | $43.88B | $189.35B | $40.40B | |
| Revenue | $510.0M | $852.5M | $8.19B | $4.71B | |
| Profit | $237.8M | $219.1M | $2.67B | $230.0M | |
| Revenue growthChange in sales versus the prior year. | 75.7% | 115.1% | 42.1% | 7.1% | 42.1% |
| Gross marginShare of sales left after the direct cost of producing them. | 39.0% | 75.7% | 51.0% | 57.7% | 57.7% |
| Operating marginShare of sales left after running the business, before interest and tax. | -28.6% | 20.3% | 16.1% | 10.4% | 16.1% |
| Profit marginProfit kept from each dollar of sales. | 46.6% | 25.7% | 32.6% | 4.9% | 25.7% |
| Free cash flow marginCash left after capital spending, as a share of sales. | -77.0% | 33.1% | 17.0% | 18.5% | 18.5% |
| Return on equityProfit against the owners' stake in the company. | -41.1% | 16.1% | 18.7% | 3.6% | 16.1% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | — | 11.5% | 7.2% | 3.5% | 7.2% |
| P/E ratioPrice paid per dollar of annual profit. | 106.71x | 200.23x | 70.91x | 175.63x | 175.63x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | — | — | 123.77x | 38.71x | 81.24x |
| Price to book | -43.86x | 32.18x | 13.23x | 6.28x | 13.23x |
| Debt to equityTotal liabilities compared with owners' stake. | -5.02x | 0.12x | 0.56x | 1.23x | 0.56x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 4/8 | 5/8 | 8/9 | 7/9 | 7.0 |
| Bankruptcy riskAltman Z-Score zone. | safe | safe | safe | safe |
How CBRS compares with the others
- CBRS's operating margin of -28.6% is lower than the median of the other companies selected (16.1%).
- Its revenue grew faster than the median of the other companies selected: 75.7% against 42.1%.
- It trades at a lower P/E than the median of the other companies selected: 106.7x against 175.6x.
- Its liabilities are lower relative to equity than the median of the other companies selected: -5.0x against 0.6x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.